In addition, Andriani et al [46] showed increased sensitivity to cisplatin after applying a FHIT gene into the NSCLC cells, and Bian et al [47] reported increasing cisplatin sensitivity of NSCLC cells by up-regulation of miRNA451. This evidence concerns the gene FHIT and non-small cell lung carcinoma.